Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 50 P323 | DOI: 10.1530/endoabs.50.P323

SFEBES2017 Poster Presentations Obesity and Metabolism (31 abstracts)

A randomised controlled trial of vitamin D treatment on markers of liver fibrosis in obese women with Polycystic Ovary Syndrome

Zeeshan Javed 1 , Eric Kilpatrick 2 , Vincent Mann 3 , Lynsey Corless 3 , George Abouda 3 , Alan Rigby 4 , Stephen Atkin 5 & Thozhukat Sathyapalan 1

1Hull York Medical School/University of Hull, Hull, UK; 2Sidra Medical and Research Center, Doha, Qatar; 3Hull Royal Infirmary, Hull, UK; 4University of Hull, Hull, UK; 5Weill Cornell Medical College Qatar, Doha, Qatar.

Context: Polycystic ovary syndrome (PCOS) has been linked to non-alcoholic fatty liver disease (NAFLD) that carries an increased risk of liver cirrhosis. The Enhanced Liver Fibrosis (ELF) score comprises serum hyaluronic acid (HA), procollagen III N-terminal peptide (PIIINP) and tissue inhibitor of metalloproteinase-1 (TIMP1) that correlate with hepatic fibrosis staging.

Objective: To determine the effect of vitamin D supplementation on liver fibrosis markers.

Design: A randomized, double-blind, placebo-controlled study.

Setting: A tertiary care setting in the UK.

Participants: Forty obese women with PCOS.

Intervention: Randomization to either vitamin D 3200 IU daily or placebo for 3 months.

Main outcome measures: The primary outcome was ELF score change, with alanine aminotransferase (ALT), hormonal, metabolic and cardiovascular risk marker changes as secondary outcomes.

Results: Vitamin D supplementation showed an ELF score reduction compared to placebo (−7.6±9.6% vs. 0.4±8.9; P=0.02) with a corresponding decrease in the component fibrosis markers; HA (−31.2±31.9% vs 16.9±57.1; P<0.01) and PIIINP (−18.6±20.4% vs 8.0±27.2; P<0.01), and a fall in ALT with vitamin D treatment (−16.7±25.7% vs 21.9±28.3; P<0.01). Within group analysis revealed vitamin D alone showed ELF score reduction (P<0.01) with a reduction in HA (P<0.01), PIIINP (P<0.01) and TIMP-1 (P<0.05). There were no changes in the hormonal, metabolic or cardiovascular risk profiles between groups.

Conclusion: Vitamin D supplementation improved hepatic fibrosis markers (HA, PIIINP, TIMP-1) in obese women with PCOS with a reduction in the ELF score.

Volume 50

Society for Endocrinology BES 2017

Harrogate, UK
06 Nov 2017 - 08 Nov 2017

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.